Global DLBCL Therapeutics Market Gains Momentum Through Targeted B-Cell Therapies
The global Diffuse Large B-Cell Lymphoma (DLBCL) therapeutics market is entering a pivotal era of clinical transformation. Driven by rapid advancements in precision medicine, antibody-drug conjugates (ADCs), chimeric antigen receptor (CAR) T-cell therapies, and bispecific antibodies, the management of both newly diagnosed and relapsed/refractory (R/R) DLBCL is evolving at an...
0 Комментарии 0 Поделились 747 Просмотры 0 предпросмотр
Urh Social https://urh.app